Sol-Gel Technologies (SLGL) Payables (2016 - 2026)
Sol-Gel Technologies' (SLGL) quarterly Payables came in at $782000.0 in Q1 2026, up 78.54% year-on-year from $438000.0 in Q1 2025, and up 6.39% on a QoQ basis from $735000.0 in Q4 2025.
Sol-Gel Technologies (SLGL) Payables (2016 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 11 years of Payables data on file, last reported at $782000.0 in Q1 2026.
- On a quarterly basis, Payables rose 78.54% year-over-year to $782000.0 in Q1 2026; TTM through Mar 2026 was $782000.0, a 78.54% increase from a year earlier, with the FY2025 full-year figure at $735000.0, down 41.9% from the prior year.
- Payables for Q1 2026 stood at $782000.0, up from $735000.0 in the prior quarter.
- Over the last five years, Payables for SLGL reached as high as $1.5 million in Q3 2024 and fell as low as $154000.0 in Q4 2023.
- Historically, Payables has averaged $680529.4 across 5 years, with a median of $679000.0 in 2024.
- Across the five-year window, Payables slumped 87.06% in 2022 and surged 721.43% in 2024, its largest moves.
- Year by year, Payables stood at $251000.0 in 2022, then tumbled by 38.65% to $154000.0 in 2023, then surged by 721.43% to $1.3 million in 2024, then sank by 41.9% to $735000.0 in 2025, then advanced by 6.39% to $782000.0 in 2026.
- Per Business Quant data, the three most recent Payables figures were $782000.0 in Q1 2026, $735000.0 in Q4 2025, and $828000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Sol-Gel Technologies | 227.58 Mn | 217.44 Mn | - | 782,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 782,000.00 |
| Dec 31, 2025 | 735,000.00 |
| Sep 30, 2025 | 828,000.00 |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 438,000.00 |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | 1.52 Mn |
| Jun 30, 2024 | 679,000.00 |
| Mar 31, 2024 | 582,000.00 |
| Dec 31, 2023 | 154,000.00 |
| Sep 30, 2023 | 234,000.00 |
| Jun 30, 2023 | 461,000.00 |
| Mar 31, 2023 | 339,000.00 |
| Dec 31, 2022 | 251,000.00 |
| Sep 30, 2022 | 167,000.00 |
| Jun 30, 2022 | 860,000.00 |
| Mar 31, 2022 | 1.11 Mn |
| Dec 31, 2021 | 766,000.00 |
| Sep 30, 2021 | 1.29 Mn |
| Jun 30, 2021 | 1.35 Mn |